تحلیل اختیاری محصول
با اجازه شما، از تحلیلهای محدود و حریمخصوصیمحور استفاده میکنیم تا مسیرهای پژوهشی مؤثر را بشناسیم. از ردیاب تبلیغاتی یا بازپخش نشست استفاده نمیکنیم. این انتخاب را میتوانید در تنظیمات تغییر دهید. بخوانید سیاست حفظ حریم خصوصی.
Nucor Corporation's published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $53.5B | |
|---|---|---|
| Revenue (ttm) | 38.8B | |
| Net income (ttm) | 3.6B | |
| EPS (ttm) | $15.7 | |
| Shares out | 226.9M | |
| P/E (trailing) | 17.3x | |
| P/E (forward) | 11.4x | |
| Dividend | $2.24 (0.83%) | |
| Volume | 1,659,243 | |
| Beta | 1.85 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $36.48B | $41.51B | $34.71B | $30.73B | $32.49B | -2.9% |
| Gross profit | $3.46B | $2.00B | $1.39B | $627.0M | $3.88B | +2.9% |
| Operating income | $9.36B | $10.51B | $6.52B | $3.13B | $2.63B | -27.2% |
| Net income | $6.83B | $7.61B | $4.53B | $2.03B | $1.74B | -28.9% |
| EPS (diluted) | $23.16 | $28.79 | $18.00 | $8.46 | $7.52 | -24.5% |
| EBITDA | $10.23B | $11.57B | $7.69B | $4.49B | $4.11B | -20.4% |
| R&D | — | — | — | — | — | — |
| SG&A | $1.71B | $2.00B | $1.59B | $1.12B | $1.22B | -8.1% |
Recent company headlines from major financial publishers.
The base case represents the modal expected cyclical recovery path synthesized across forward earnings, multi-stage moat fade, owner earnings, and FCFF DCF models. Consolidated revenue recovers 24.63% in FY2026 to $40.50B before decelerating toward long-term nominal economic growth of 2.0% to 2.5%. Operating margins rebound to 13.50% in FY2026 and normalize to 10.00% by FY2030, in line with mid-cycle historical averages and direct mini-mill peer STLD (11.50%). Capital expenditures step down from peak transformation intensity of $3,422M in FY2025, restoring annual free cash flow above $2.5B.
Accelerated commercial ramp of the West Virginia sheet mill and persistent margin expansion driven by captive DRI cost advantages and record downstream backlogs drive fundamental intrinsic value toward the upper valuation boundary. Operating margins expand beyond 12.5% as non-residential construction and federal infrastructure spending sustain consolidated revenue above $40B, and capital expenditures normalize toward $2.0B, unlocking over $3.5B in free cash flow and accelerating counter-cyclical share repurchases.
| Ke ↓ / g → | 2.0% | 2.3% | 2.5% | 2.8% | 3.0% |
|---|---|---|---|---|---|
| 10.4% | $161 | $163 | $165 | $168 | $170 |
| 10.9% | $155 | $156 | $158 | $160 | $162 |
| 11.4% | $149 | $150 | $154 | $154 | $156 |
| 11.9% | $143 | $145 | $146 | $148 | $149 |
| 12.4% | $139 | $140 | $141 | $142 | $144 |
Upcoming earnings date and setup when available.
رتبهای که نسخهٔ پژوهشی منتشرشدهٔ هر ماه داشت. رتبه قیمت در تاریخ تحلیل را با ارزش منصفانه مقایسه میکند و سابقهای از درستی یا نادرستی ارزیابی نیست.
| سال | دی | بهمن | اسفند | فروردین | اردیبهشت | خرداد | تیر | مرداد | شهریور | مهر | آبان | آذر |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
